The United States National Institutes of Health, the Centers for AIDS Research and the International AIDS Society announce a new round of innovative HIV research awards
21 July 2012 (Geneva, Switzerland) - The International AIDS Society (IAS), in partnership with the U.S. National Institutes of Health (NIH) and the NIH-supported Centers for AIDS Research (CFAR),
today announced the launch of the special round Toward an HIV Cure of the joint research grant programme, Creative and Novel Ideas in HIV
The special round of the CNIHR programme supports innovative proposals to accelerate the search toward an HIV cure from
early-stage scientists new to this research field. "This international partnership is designed to promote innovative research from
early-stage investigators who will bring novel ideas and new technologies to research toward a cure for HIV/AIDS," Dr Jack
Whitescarver, NIH Associate Director for AIDS Research and Director of the Office of AIDS Research, said. "AIDS
researchers are making strides, and we need to stimulate creative ideas and build multi-disciplinary
international collaborations." "As in other scientific fields, we often see the most exciting ideas
from our newest investigators. They also come with new networks of collaborators, further adding
value to this crucial investment in the future of HIV science", adds Prof Paul Volberding,
co-director with Warner Greene of the UCSF-GIVI CFAR in San Francisco California.
Given the limited resources available to pursue the rollout of antiretroviral therapy (ART) to all who need it, as well
as the fact that in certain regions, new infections continue to outpace the number of people on treatment, there is a strong need for
continued investments to find new strategies with the potential to contribute to an HIV Cure. "In the current economic climate of
treatment funding shortages and with a scale of unmet need that can only increase, the IAS is highly concerned by the long-term
sustainability of antiretroviral therapy rollout," Elly Katabira, IAS President, said. "Along with our partners, the IAS is
committed to investing in finding better and more cost-effective options to curb the epidemic. One of the ways we can
pursue this is through the Special HIV Cure Round of the CNIHR research grant programme."
The first round of grants was announced in 2010. The joint programme awarded a total of US$3.4 million to fund the research projects
of ten outstanding early-stage researchers. In 2012, CNIHR grants which total US$5 million will be awarded to 12 researchers at the XIX
International AIDS Conference. Each awardee is funded for up to two years with up to $150,000 (direct costs) per year plus applicable
"The truly international nature of this programme - it is open to candidates globally - enables it to select the best
research projects from all over the world," Prof Michael Saag, Director of CFAR at the University of Alabama at Birmingham,
commented. "CNIHR awardees come from a wide range of scientific disciplines and locations, including Argentina, Australia,
India, Mexico, South Africa, the United Kingdom and the United States."
The first step of the competitive application process is now open on the CNIHR website (www.cnihr.org) and will close on
5 October 2012. Applicants will be asked to complete a two-step process to assess the quality of their research projects. Awardees will
be selected by mid-April 2013 and will be able to start their research projects in June 2013. The research projects will be supported
in collaboration with a CFAR institution with expertise in each candidate's area of proposed research.
The brothers were actively involved in AIDS research in Iran and, along with other clinicians and
advocates, helped make the country a leader in prevention of HIV and treatment for people
living with HIV, including enlightened policies on needle exchange and one of the region's best
prison programmes. The doctors shared their knowledge by holding training workshops for
Afghan and Tajik health professionals.
"Through this programme, promising young researchers have access to CFAR's solid expertise and infrastructure, which is
extremely important for the success of their projects," Prof King Holmes, Director of the CFAR at the University of Washington, said.
Awardees will also receive a scholarship to attend a networking and training programme in conjunction with the 7th IAS Conference
on HIV Pathogenesis, Treatment and Prevention (IAS 2013), which will be held from 30 June - 3 July 2013 in Kuala Lumpur,
Malaysia, where the results of the selection process will be announced.
About the IAS
The International AIDS Society (IAS) is the world's leading independent association of HIV professionals, with over 16,000
members from more than 196 countries working at all levels of the global response to HIV. Our members include researchers from all
disciplines, clinicians, public health and community practitioners on the frontlines of the epidemic, as well as policy and
programme planners. The IAS is the custodian of the biennial International AIDS Conference, which will be held in
Washington, D.C., in July 2012, and lead organizer of the IAS Conference on HIV Pathogenesis, Treatment and Prevention.
www.iasociety.org | www.aids2012.org
About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic,
clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.
For more information about NIH and its programs, visit www.nih.gov. NIH...Turning
Discovery Into Health.
For more information:
The Centers for AIDS Research (CFAR) program at the NIH provides administrative and shared research support to synergistically enhance and
coordinate high quality AIDS research projects. CFARs accomplish this through core facilities that provide expertise, resources, and
services not otherwise readily obtained through more traditional funding mechanisms. The CFAR program emphasizes the importance of
interdisciplinary collaboration, especially between basic and clinical investigators, translational research in which findings
from the laboratory are brought to the clinic and vice versa, and an emphasis upon inclusion of minorities and inclusion of
prevention and behavioral change research.
Siân Bowen (Geneva, Switzerland)
Senior Manager, Communications
Tel: +41 22 710 0864
US Mob (July 16-28): +1 202 997 6935
Francesca Da Ros (Geneva, Switzerland)
Communications and Media Officer
Tel: +41 22 710 0822
Mob: +41 796 109679
US Mob (July 16-28): +1 202 997 6917
"Reproduced with permission - International AIDS Society"
International AIDS Society
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS: